1-Naphthylboronic Acid

We are 1-Naphthylboronic Acid CAS:13922-41-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: 1-Naphthylboronic Acid
Other Name:
1-Naphthylboronic Acid
1-Naphthaleneboronic Acid
1-Naphthaleneboronicacid
CAS No: 13922-41-3
MF: C10H9BO2
MW: 171.98800
Density: 1.21 g/cm3
Boiling point: 381.9ºC at 760 mmHg
Melting point: 208-214 °C(lit.)
Flash point: 184.8ºC
Refractive index: 1.638
UN Number: Not dangerous goods.
UN Proper Shipping Name: Not dangerous goods.
Transport hazard class: Not dangerous goods.
Packing group: Not dangerous goods.
 
Specification
Appearance: White powder
Assay: ≥98.0%
Water: ≤0.50%
 
Application
Be used as pharmaceutical intermediate.
B-1-Naphthalenyl-boronic Acid is a useful synthetic intermediate. It is a reagent used to synthesize potassium aryltrifluoroborates which is a convenient precursor of arylboron difluoride lewis acids. It can also be used to prepare high yields of biaryls via Suzuki coupling.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

1-Naphthylboronic Acid


Related News: The company’s product reserves are rich, with more than one hundred varieties in various categories from intermediates to APIs. At present, the grays and anti-hepatitis C series intermediates are steadily advancing, which will ensure future growth.2-bromo-1- (2,4-diclorofenil) etanona CAS:2631-72-3 In addition to APIs, a variety of pharmaceutical excipients are contained in the medicine.897671-69-1 According to the “2013-2018 New Drug Review Summary” report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.2-Fluoro-5-(trifluoromethoxy)benzoic acid CAS:886497-85-4 Human iPSCs possess the unique dual properties of unlimited self-renewal and differentiation potential into all cell types of the body.The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data.

Related Products
Product Name
1,9-Decadiene View Details
3-(3-amino-2-hydroxyphenyl)benzoic acid View Details
Tetraethylammonium bromide View Details
4′-Chloroacetoacetanilide manufacturer Methyl 2-methoxy-5-sulfamoylbenzoate manufacturer 2-Chloroacrylonitrile manufacturer PEPTIDE YY, HUMAN manufacturer 6-Chloro-9-(tetrahydropyran-2-yl)purine manufacturer